Sanofi and GlaxoSmithKline said they expect data from late-stage clinical trials of its booster dose of their COVID-19 vaccine candidate in the first quarter next year, instead of this year, another delay for the potential shot
said on Wednesday they expect data from late-stage clinical trials of its booster dose of their COVID-19 vaccine candidate in the first quarter, instead of this year, another delay for the potential shot.
The news came as the French and British partners said preliminary data from trials showed the single-dose booster provided strong immune responses. The companies said they need more time to test the booster on more people who have not been infected by the virus before they can submit data to regulators.The Phase III trial for the recombinant adjuvanted COVID-19 vaccine recruited most participants in the third quarter, coinciding with a significant increase in the number of people infected globally due to the Delta variant, it said.
"To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022."This is the latest delay for the vaccine's development, putting the companies further behind rivals in the race for COVID-19 shots.
They were forced to start a new clinical trial of the vaccine candidate after trials last year showed an insufficient immune response in older people.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
COVID-19 Vaccine Education and Equity Project’s Statement on the Anniversary of the Authorization of the First COVID-19 Vaccines - COVID-19 Vaccine Education and Equity ProjectCOVID-19 Vaccine Education and Equity Project’s Statement on the Anniversary of the Authorization of the First COVID-19 Vaccines To mark the milestone one-year anniversary of the authorization of the first COVID-19 vaccines in the U.S., the conveners of the COVID-19 Vaccine Education and Equity Project shared the following statements...
Consulte Mais informação »
U.S. Air Force removes 27 service members for refusing COVID-19 vaccineThe U.S. Air Force on Monday said 27 service members had been discharged for refusing to receive a COVID-19 vaccine, the first active-duty troops believed to have been removed for declining the vaccine.
Consulte Mais informação »
Air Force Discharges 27 Active Duty Service Members for Refusing Covid-19 VaccineThe U.S. Air Force discharged 27 airmen for refusing to get a coronavirus vaccine. They're among the first active duty service members to be removed for not meeting the mandate.
Consulte Mais informação »
Only half of US nursing home residents have received a Covid-19 vaccine boosterOnly about half of fully vaccinated nursing home residents have received a booster dose of Covid-19 vaccine, leaving a high-risk group especially vulnerable as Covid-19 cases rise across the country and concern about the Omicron variant builds.
Consulte Mais informação »
NFL requiring COVID-19 booster shots by Dec. 27The NFL is requiring players, coaches and other team personnel to receive a COVID-19 booster by Dec. 27.
Consulte Mais informação »
Evanescence Postpone Tour Dates Due to Multiple Covid-19 CasesEvanescence have postponed their remaining 2021 tour dates with Halestorm due to multiple Covid-19 cases within their touring party
Consulte Mais informação »